These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29491234)

  • 41. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease.
    Abe M; Miyake T; Kuno A; Imai Y; Sawai Y; Hino K; Hara Y; Hige S; Sakamoto M; Yamada G; Kage M; Korenaga M; Hiasa Y; Mizokami M; Narimatsu H
    J Gastroenterol; 2015 Jul; 50(7):776-84. PubMed ID: 25326152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein but not α-fetoprotein as a Long-Term Hepatocellular Carcinoma Predictor.
    Osawa L; Tamaki N; Kurosaki M; Kirino S; Watakabe K; Wang W; Okada M; Shimizu T; Higuchi M; Takaura K; Takada H; Kaneko S; Yasui Y; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Enomoto N; Izumi N
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Daily Monitoring of Serum Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein Is Useful for Predicting Therapeutic Effect of Tolvaptan in Cirrhotic Ascites.
    Takamura M; Sakamaki A; Arao Y; Setsu T; Kamimura H; Yokoo T; Kamimura K; Tsuchiya A; Terai S
    Tohoku J Exp Med; 2020 Dec; 252(4):287-296. PubMed ID: 33208569
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Tamaki N; Kurosaki M; Takahashi Y; Itakura Y; Kirino S; Inada K; Yamashita K; Sekiguchi S; Hayakawa Y; Osawa L; Higuchi M; Takaura K; Maeyashiki C; Kaneko S; Yasui Y; Tsuchiya K; Nakanishi H; Itakura J; Loomba R; Izumi N
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-glycan structures of Wisteria floribunda agglutinin-positive Mac2 binding protein in the serum of patients with liver fibrosis†.
    Noro E; Matsuda A; Kyoutou T; Sato T; Tomioka A; Nagai M; Sogabe M; Tsuruno C; Takahama Y; Kuno A; Tanaka Y; Kaji H; Narimatsu H
    Glycobiology; 2021 Nov; 31(10):1268-1278. PubMed ID: 34192302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel glycobiomarker, Wisteria floribunda agglutinin macrophage colony-stimulating factor receptor, for predicting carcinogenesis of liver cirrhosis.
    Iio E; Ocho M; Togayachi A; Nojima M; Kuno A; Ikehara Y; Hasegawa I; Yatsuhashi H; Yamasaki K; Shimada N; Ide T; Shinkai N; Nojiri S; Fujiwara K; Joh T; Mizokami M; Narimatsu H; Tanaka Y
    Int J Cancer; 2016 Mar; 138(6):1462-71. PubMed ID: 26437001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Role of Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Level in Early Stage Hepatocellular Carcinoma.
    Lin J; Ko CJ; Hung YJ; Lin PY; Lin KH; Hsieh CE; Chou CT; Chen YL
    Sci Rep; 2020 Mar; 10(1):5651. PubMed ID: 32221384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Ichikawa Y; Joshita S; Umemura T; Shobugawa Y; Usami Y; Shibata S; Yamazaki T; Fujimori N; Komatsu M; Matsumoto A; Tanaka E
    Hepatol Res; 2017 Feb; 47(2):226-233. PubMed ID: 27029022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts the development of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
    Kawanaka M; Tomiyama Y; Hyogo H; Koda M; Shima T; Tobita H; Hiramatsu A; Nishino K; Okamoto T; Sato S; Hara Y; Nishina S; Kawamoto H; Chayama K; Okanoue T; Hino K
    Hepatol Res; 2018 Jun; 48(7):521-528. PubMed ID: 29316028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis.
    Nakamura M; Kanda T; Jiang X; Haga Y; Takahashi K; Wu S; Yasui S; Nakamoto S; Yokosuka O
    PLoS One; 2017; 12(5):e0177302. PubMed ID: 28475652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein level as a diagnostic marker of hepatitis B virus-related hepatocellular carcinoma.
    Chuaypen N; Chittmittraprap S; Pinjaroen N; Sirichindakul B; Poovorawan Y; Tanaka Y; Tangkijvanich P
    Hepatol Res; 2018 Oct; 48(11):872-881. PubMed ID: 29732647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein can reflect systemic lupus erythematosus activity.
    Ahn SS; Park Y; Lee DD; Bothwell ALM; Jung SM; Song JJ; Park YB; Lee SW
    Lupus; 2018 Apr; 27(5):771-779. PubMed ID: 29233037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical implications of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein in treatment-naïve chronic hepatitis B.
    Ishii A; Nishikawa H; Enomoto H; Iwata Y; Kishino K; Shimono Y; Hasegawa K; Nakano C; Takata R; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Hepatol Res; 2017 Feb; 47(2):204-215. PubMed ID: 26990490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis.
    Nishikawa H; Enomoto H; Iwata Y; Hasegawa K; Nakano C; Takata R; Nishimura T; Yoh K; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Hepatol Res; 2016 Jun; 46(7):613-21. PubMed ID: 26406984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Significant association between serum Wisteria floribunda agglutinin-positive Mac-2-binding protein and prognosis of hepatocellular carcinoma after surgical treatment.
    Lin MT; Chiu SY; Chang KC; Li WF; Yong CC; Liu YW; Wang JH; Kuo FY; Huang CC; Wang CC; Hsiao CC; Hu TH
    Am J Cancer Res; 2022; 12(2):601-614. PubMed ID: 35261790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A proposed predictive model for advanced fibrosis in patients with chronic hepatitis B and its validation.
    Nishikawa H; Hasegawa K; Ishii A; Takata R; Enomoto H; Yoh K; Kishino K; Shimono Y; Iwata Y; Nakano C; Nishimura T; Aizawa N; Sakai Y; Ikeda N; Takashima T; Iijima H; Nishiguchi S
    Medicine (Baltimore); 2016 Aug; 95(35):e4679. PubMed ID: 27583895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein more reliably distinguishes liver fibrosis stages in non-alcoholic fatty liver disease than serum Mac-2 binding protein.
    Atsukawa M; Tsubota A; Okubo T; Arai T; Nakagawa A; Itokawa N; Kondo C; Kato K; Hatori T; Hano H; Oikawa T; Emoto N; Abe M; Kage M; Iwakiri K
    Hepatol Res; 2018 May; 48(6):424-432. PubMed ID: 29274190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum aldo-keto reductase family 1 member B10 predicts advanced liver fibrosis and fatal complications of nonalcoholic steatohepatitis.
    Kanno M; Kawaguchi K; Honda M; Horii R; Takatori H; Shimakami T; Kitamura K; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
    J Gastroenterol; 2019 Jun; 54(6):549-557. PubMed ID: 30707282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Post-treatment serum Wisteria floribunda agglutinin-positive mac-2-binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
    Sato S; Tsuzura H; Kita Y; Ikeda Y; Kabemura D; Sato S; Amano N; Yatagai N; Murata A; Shimada Y; Genda T
    JGH Open; 2021 Oct; 5(10):1203-1209. PubMed ID: 34622009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical significance of serum Wisteria floribunda agglutinin positive Mac-2-binding protein level in non-alcoholic steatohepatitis.
    Nishikawa H; Enomoto H; Iwata Y; Kishino K; Shimono Y; Hasegawa K; Nakano C; Takata R; Yoh K; Nishimura T; Aizawa N; Sakai Y; Ikeda N; Takashima T; Ishii A; Iijima H; Nakamura H; Nishiguchi S
    Hepatol Res; 2016 Nov; 46(12):1194-1202. PubMed ID: 26836229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.